This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mann, D. L. Search for Related Content PubMed PubMed Citation Articles by Mann, D. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cardiomyopathy

(Circulation. 2001;103:626.)
© 2001 American Heart Association, Inc.

Editorials

Tumor Necrosis Factor and Viral Myocarditis: The Fine Line Between Innate and Inappropriate Immune Responses in the Heart

Douglas L. Mann, MD

From Winters Center for Heart Failure Research; the Cardiology Section, Department of Medicine, Baylor College of Medicine; and the Houston Veterans Administration Medical Center, Houston Texas.

Correspondence to Douglas L. Mann, MD, Cardiology Research (151C), VA Medical Center, 2002 Holcombe Blvd, Houston, TX 77030. E-mail dmann@bcm.tmc.edu

Key Words: Editorials • tumor necrosis factor • myocarditis • cytokines • inflammation

"In this world there are only two tragedies. One is not getting what one wants, and the other is getting it."—Oscar Wilde

Tumor necrosis factor (TNF) has been referred to a "mixed blessing for higher organisms."¹ That is to say, although the controlled self-limited expression of TNF plays a critical role in activating host defense mechanisms and in homeostatic tissue repair, uncontrolled overexpression of TNF produces devastating consequences for the host organism, frequently leading to diffuse inflammation, multiorgan dysfunction, hemodynamic collapse, and death. Although a similar "bifunctional picture" for TNF has not yet emerged clearly for the heart, the report by Wada and colleagues² in the present issue of Circulation suggests that TNF may be a mixed blessing for the heart as well.

Several lines of evidence suggest that proinflammatory cytokines, such as TNF, play an important role in the pathogenesis of viral myocarditis. For example, elevated levels of TNF have been reported in patients with viral myocarditis.³ Importantly, TNF mRNA and protein are consistently upregulated in the hearts of patients with viral myocarditis.⁴ Mice with targeted overexpression of TNF in the cardiac compartment develop florid myocarditis and progressive myocardial fibrosis.^{5 6} The exogenous administration of TNF aggravates myocarditis, and the neutralization of TNF by antibodies or soluble receptors attenuates viral myocarditis.^{7 8} Taken together, these observations suggest that TNF plays an important pathophysiological role in the development and progression of viral myocarditis. In the present issue of Circulation, Wada and colleagues² report that mice with targeted disruption of the TNF . . . [Full Text of this Article]

This article has been cited by other articles:

				J. A. Carroll Bidirectional communication: Growth and immunity in domestic livestock J Anim Sci, April 1, 2008; 86(14_suppl): E126 - E137. [Abstract] [Full Text] [PDF]

				L. Guilherme, P. Cury, L. M.F. Demarchi, V. Coelho, L. Abel, A. P. Lopez, S. E. Oshiro, S. Aliotti, E. Cunha-Neto, P. M.A. Pomerantzeff, et al. Rheumatic Heart Disease: Proinflammatory Cytokines Play a Role in the Progression and Maintenance of Valvular Lesions Am. J. Pathol., November 1, 2004; 165(5): 1583 - 1591. [Abstract] [Full Text] [PDF]

				T. Peng, X. Lu, M. Lei, and Q. Feng Endothelial Nitric-oxide Synthase Enhances Lipopolysaccharide-stimulated Tumor Necrosis Factor-alpha Expression via cAMP-mediated p38 MAPK Pathway in Cardiomyocytes J. Biol. Chem., February 28, 2003; 278(10): 8099 - 8105. [Abstract] [Full Text] [PDF]

				A. Martire, B. Fernandez, A. Buehler, C. Strohm, J. Schaper, R. Zimmermann, P. E Kolattukudy, and W. Schaper Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation Cardiovasc Res, February 1, 2003; 57(2): 523 - 534. [Abstract] [Full Text] [PDF]

				Y. Sun, J. Zhang, L. Lu, S. S. Chen, M. T. Quinn, and K. T. Weber Aldosterone-Induced Inflammation in the Rat Heart : Role of Oxidative Stress Am. J. Pathol., November 1, 2002; 161(5): 1773 - 1781. [Abstract] [Full Text] [PDF]

				R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF]

				R. M Smith, N. Suleman, J. McCarthy, and M. N Sack Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF{alpha} gene Cardiovasc Res, August 15, 2002; 55(3): 553 - 560. [Abstract] [Full Text] [PDF]

				F. de' Clari, I. Salani, E. Safwan, and A. Giannacco Sudden Death in a Patient Without Heart Failure After a Single Infusion of 200 mg Infliximab: Does TNF-{alpha} Have Protective Effects on the Failing Heart, or Does Infliximab Have Direct Harmful Cardiovascular Effects? Circulation, May 28, 2002; 105 (21): e183 - e183. [Full Text] [PDF]